million increased by Baht 19.77 million or 9.29% from the quarter 3/2017, mainly due to increase of export sales. 2) Cost of sales increased by Baht 2.98 million. The increased of cost of sales due to

: amounting of Baht 183.97 million). 2) Cost of sales decreased by Baht 18.03 million due to sales amount decreased. Cost of sales ratio at 88.37% (2019 : at 87.70%) which effected to the company has a gross

no any impact from COVID-19 pandemic in Quarter 2/2020. 2) Cost of sales decreased by Baht 14.97 million, cost of sales ratio at 77.77% (2019 : at 86.59%) which effected to the company has a gross

mobile check-up cost, nurses and medical staff salary, medicine cost. The company’s gross profit in Q2/2017 was THB 34.82 million, slightly decreased from THB 35.06 in Q2/2016. The company’s net income in

, 2017 as in the consolidate financial statement has net loss 7.78 Million Baht, increase of 15.25 Million Baht or 204.20% comparing to the last year. Loss attributable to equity holders of the parent is

Grand Rama 9 to accurately reflect the project’s cost of sale. Weighted average financing cost as of March 31, 2020 stood at 2.65% Net debt to equity ratio stood at 0.38x Capital Structure As of March 31

increased to 0.68 times because of the record of construction cost refund from Tubma reservoir development project. Debt to equity ratio was at 0.83 times and Debt service coverage ratio (DSCR) remained

ended 30 June % changes 2019 2018 Increase (decrease) Sales 134,591 179,969 (25.21) Total revenues 333,590 195,327 70.79 Cost of sales 152,878 172,470 (11.36) Selling and administrative expenses 18,982

results (Unit : 1,000 Baht) Q2 ended 30th June % changes 2020 2019 Increase (decrease) Sales 143,788 134,591 6.83 Total revenues 165,612 333,418 (50.33) Cost of sales 132,505 152,878 (13.33) Selling and

Company reported Cost of Hospital Operations including Depreciation and Amortization of Baht 382.14 million in 2018, or 12.72% increase year-over-year from Baht 339.01 million in 2017. This represents an